ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
54121.1 IP-LS
Project title
alphaRep-HR2 entry inhibitors and a non-antigenic test for the treatment and diagnosis of COVID-19
Project status Finished
 
Start date 01.06.2021
End date 01.01.2023
 
Granted total costs 352'488.60  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
 
Research disciplines
100 % T410 Pharmaceuticals and related technologies
Last modification of the project